New Drugs in the Treatment of Erectile Dysfunction
Authors:
K. Kočí
Authors‘ workplace:
Andromeda, Praha, vedoucí lékař MUDr. K. Kočí, CSc.
Published in:
Prakt. Lék. 2003; (10): 582-584
Category:
Overview
Erectile dysfunction (ED) is a warning symptom of a potential latent serious disease (e.g.cardiovascular diseases, DM). A physician, notwithstanding his specialization, should be ableto speak openly with his patients about their sexual health, and in need to carry out a basicexamination and afford adequate therapy. Presently, in the treatment of EDthere predominatesoral pharmacotherapy with single applications preceding each coitus. Available are now threeproducts - sildenafil, apomorphine, and tadalafil, differing in their characteristics and facilitatingtargeted and individually adjusted treatment. None of these three drugs influence thepatient’s appetency or orgastic experience. Simply, in question there are specific penilevasodilatators. The newest of them, tadalafil, is of significantly longer action in comparison withthe other two.
Key words:
erectile dysfunction - pharmacotherapy - oral treatment - tadalafil.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2003 Issue 10
Most read in this issue
- Consensus on Antibiotics Application II. Macrolide Antibiotics
- Open-angle Glaucoma - Known and Possible Risk FactorsI. Influence of Elevated Intraocular Pressure and its Reduction on Glaucoma Progression
- Fatigue and Fatigue Syndromes. Part III.
- Who Treats Patients with Chronic Pain?Discrepancies between the Results of Two Pilot Studies in Project Algos